1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Introduction
5.2. Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
5.3. Key Trends Analysis
5.3.1. Demand Side Analysis
5.3.2. Supply Side Analysis
5.4. Key Market Indicators
5.5. Technological Overview Analysis
5.6. Porter’s Five Forces Analysis
5.7. Industry SWOT Analysis
5.8. Value Chain Analysis
5.9. Regulatory Framework
5.10. Global Liquid Biopsy Market Analysis and Forecast, – 2017–2031
5.10.1. Market Value Projections (US$ Mn)
6. Global Liquid Biopsy Market Analysis and Forecast, by Application
6.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
6.1.1. Oncology
6.1.2. NIPT
6.1.3. Transplant Diagnostics
6.1.4. Others
6.2. Incremental Opportunity, by Application
7. Global Liquid Biopsy Market Analysis and Forecast, by Circulating Biomarker
7.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
7.1.1. Circulating Tumor Cells (CTC)
7.1.2. Free Nucleic Acid
7.1.3. Exracellular Vesicles/Exosomes
7.2. Incremental Opportunity, by Circulating Biomarker
8. Global Liquid Biopsy Market Analysis and Forecast, by End-user
8.1. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
8.1.1. Hospitals
8.1.2. Reference Laboratories
8.1.3. Academic and Research Institutes
8.1.4. Others
8.2. Incremental Opportunity, by End-user
9. Global Liquid Biopsy Market Analysis and Forecast, by Region
9.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Region, 2017–2031
9.1.1. North America
9.1.2. Europe
9.1.3. Asia Pacific
9.1.4. Middle East & Africa
9.1.5. South America
9.2. Incremental Opportunity, by Region
10. North America Liquid Biopsy Market Analysis and Forecast
10.1. Regional Snapshot
10.2. Brand Analysis
10.3. Price Trend Analysis
10.3.1. Weighted Average Price
10.4. Key Trends Analysis
10.4.1. Demand Side
10.4.2. Supplier Side
10.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
10.5.1. Oncology
10.5.2. NIPT
10.5.3. Transplant Diagnostics
10.5.4. Others
10.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
10.6.1. Circulating Tumor Cells (CTC)
10.6.2. Free Nucleic Acid
10.6.3. Exracellular Vesicles/Exosomes
10.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user – 2017–2031
10.7.1. Hospitals
10.7.2. Reference Laboratories
10.7.3. Academic and Research Institutes
10.7.4. Others
10.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country – 2017–2031
10.8.1. U.S.
10.8.2. Canada
10.8.3. Rest of North America
10.9. Incremental Opportunity Analysis
11. Europe Liquid Biopsy Market Analysis and Forecast
11.1. Regional Snapshot
11.2. Brand Analysis
11.3. Price Trend Analysis
11.3.1. Weighted Average Price
11.4. Key Trends Analysis
11.4.1. Demand Side
11.4.2. Supplier Side
11.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
11.5.1. Oncology
11.5.2. NIPT
11.5.3. Transplant Diagnostics
11.5.4. Others
11.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
11.6.1. Circulating Tumor Cells (CTC)
11.6.2. Free Nucleic Acid
11.6.3. Exracellular Vesicles/Exosomes
11.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
11.7.1. Hospitals
11.7.2. Reference Laboratories
11.7.3. Academic and Research Institutes
11.7.4. Others
11.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
11.8.1. U.K.
11.8.2. Germany
11.8.3. France
11.8.4. Rest of Europe
11.9. Incremental Opportunity Analysis
12. Asia Pacific Liquid Biopsy Market Analysis and Forecast
12.1. Regional Snapshot
12.2. Brand Analysis
12.3. Price Trend Analysis
12.3.1. Weighted Average Price
12.4. Key Trends Analysis
12.4.1. Demand Side
12.4.2. Supplier Side
12.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
12.5.1. Oncology
12.5.2. NIPT
12.5.3. Transplant Diagnostics
12.5.4. Others
12.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
12.6.1. Circulating Tumor Cells (CTC)
12.6.2. Free Nucleic Acid
12.6.3. Exracellular Vesicles/Exosomes
12.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
12.7.1. Hospitals
12.7.2. Reference Laboratories
12.7.3. Academic and Research Institutes
12.7.4. Others
12.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
12.8.1. India
12.8.2. China
12.8.3. Japan
12.8.4. Rest of Asia Pacific
12.9. Incremental Opportunity Analysis
13. Middle East & South Africa Liquid Biopsy Market Analysis and Forecast
13.1. Regional Snapshot
13.2. Brand Analysis
13.3. Price Trend Analysis
13.3.1. Weighted Average Price
13.4. Key Trends Analysis
13.4.1. Demand Side
13.4.2. Supplier Side
13.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
13.5.1. Oncology
13.5.2. NIPT
13.5.3. Transplant Diagnostics
13.5.4. Others
13.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
13.6.1. Circulating Tumor Cells (CTC)
13.6.2. Free Nucleic Acid
13.6.3. Exracellular Vesicles/Exosomes
13.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
13.7.1. Hospitals
13.7.2. Reference Laboratories
13.7.3. Academic and Research Institutes
13.7.4. Others
13.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
13.8.1. GCC
13.8.2. Rest of Middle East & Africa
13.9. Incremental Opportunity Analysis
14. South America Liquid Biopsy Market Analysis and Forecast
14.1. Regional Snapshot
14.2. Brand Analysis
14.3. Price Trend Analysis
14.3.1. Weighted Average Price
14.4. Key Trends Analysis
14.4.1. Demand Side
14.4.2. Supplier Side
14.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
14.5.1. Oncology
14.5.2. NIPT
14.5.3. Transplant Diagnostics
14.5.4. Others
14.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
14.6.1. Circulating Tumor Cells (CTC)
14.6.2. Free Nucleic Acid
14.6.3. Exracellular Vesicles/Exosomes
14.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
14.7.1. Hospitals
14.7.2. Reference Laboratories
14.7.3. Academic and Research Institutes
14.7.4. Others
14.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
14.8.1. Brazil
14.8.2. Rest of South America
14.9. Incremental Opportunity Analysis
15. Competition Landscape
15.1. Market Player – Competition Dashboard
15.2. Market Share Analysis (%), by Company, (2022)
15.3. Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
15.3.1. Biocept, Inc.
15.3.1.1. Company Overview
15.3.1.2. Sales Area
15.3.1.3. Geographical Presence
15.3.1.4. Revenue
15.3.1.5. Strategy & Business Overview
15.3.2. MDxHealth
15.3.2.1. Company Overview
15.3.2.2. Sales Area
15.3.2.3. Geographical Presence
15.3.2.4. Revenue
15.3.2.5. Strategy & Business Overview
15.3.3. Myriad Genetics, Inc.
15.3.3.1. Company Overview
15.3.3.2. Sales Area
15.3.3.3. Geographical Presence
15.3.3.4. Revenue
15.3.3.5. Strategy & Business Overview
15.3.4. Bio-Rad Laboratories
15.3.4.1. Company Overview
15.3.4.2. Sales Area
15.3.4.3. Geographical Presence
15.3.4.4. Revenue
15.3.4.5. Strategy & Business Overview
15.3.5. QIAGEN
15.3.5.1. Company Overview
15.3.5.2. Sales Area
15.3.5.3. Geographical Presence
15.3.5.4. Revenue
15.3.5.5. Strategy & Business Overview
15.3.6. F. Hoffmann-La Roche Ltd.
15.3.6.1. Company Overview
15.3.6.2. Sales Area
15.3.6.3. Geographical Presence
15.3.6.4. Revenue
15.3.6.5. Strategy & Business Overview
15.3.7. Thermo Fisher Scientific, Inc.
15.3.7.1. Company Overview
15.3.7.2. Sales Area
15.3.7.3. Geographical Presence
15.3.7.4. Revenue
15.3.7.5. Strategy & Business Overview
15.3.8. Genomic Health, Inc.
15.3.8.1. Company Overview
15.3.8.2. Sales Area
15.3.8.3. Geographical Presence
15.3.8.4. Revenue
15.3.8.5. Strategy & Business Overview
15.3.9. Illumina, Inc.
15.3.9.1. Company Overview
15.3.9.2. Sales Area
15.3.9.3. Geographical Presence
15.3.9.4. Revenue
15.3.9.5. Strategy & Business Overview
15.3.10. Other Key Players
15.3.10.1. Company Overview
15.3.10.2. Sales Area
15.3.10.3. Geographical Presence
15.3.10.4. Revenue
15.3.10.5. Strategy & Business Overview
16. Go to Market Strategy
17. Identification of Potential Market Spaces
18. Prevailing Market Risks
19. Understanding Buying Process of Customers
20. Preferred Sales & Marketing Strategy
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer